INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $300 | +1.0% | 3,000 | 0.0% | 0.01% | -6.7% |
| Q1 2023 | $297 | +1.0% | 3,000 | 0.0% | 0.02% | -6.2% |
| Q4 2022 | $294 | -100.0% | 3,000 | -76.9% | 0.02% | -77.1% |
| Q3 2022 | $1,251,000 | +0.2% | 13,000 | 0.0% | 0.07% | +2.9% |
| Q2 2022 | $1,248,000 | +5.1% | 13,000 | 0.0% | 0.07% | +25.9% |
| Q1 2022 | $1,188,000 | -2.9% | 13,000 | 0.0% | 0.05% | +1.9% |
| Q4 2021 | $1,224,000 | +5.0% | 13,000 | 0.0% | 0.05% | -3.6% |
| Q3 2021 | $1,166,000 | +0.1% | 13,000 | 0.0% | 0.06% | 0.0% |
| Q2 2021 | $1,165,000 | +10.1% | 13,000 | 0.0% | 0.06% | -6.8% |
| Q1 2021 | $1,058,000 | +5.6% | 13,000 | 0.0% | 0.06% | -33.0% |
| Q4 2020 | $1,002,000 | +315.8% | 13,000 | +333.3% | 0.09% | +282.6% |
| Q3 2020 | $241,000 | +6.6% | 3,000 | 0.0% | 0.02% | +9.5% |
| Q2 2020 | $226,000 | -5.8% | 3,000 | 0.0% | 0.02% | -27.6% |
| Q1 2020 | $240,000 | -20.5% | 3,000 | 0.0% | 0.03% | +7.4% |
| Q4 2019 | $302,000 | +17.1% | 3,000 | 0.0% | 0.03% | +8.0% |
| Q3 2019 | $258,000 | -3.4% | 3,000 | 0.0% | 0.02% | -7.4% |
| Q2 2019 | $267,000 | -10.1% | 3,000 | 0.0% | 0.03% | -15.6% |
| Q1 2019 | $297,000 | +7.6% | 3,000 | 0.0% | 0.03% | -8.6% |
| Q4 2018 | $276,000 | -8.9% | 3,000 | 0.0% | 0.04% | +2.9% |
| Q3 2018 | $303,000 | +15.2% | 3,000 | 0.0% | 0.03% | +3.0% |
| Q2 2018 | $263,000 | – | 3,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 12,851,000 | $12,016,000 | 2.95% |
| Context Capital Management, LLC | 3,000,000 | $2,804,000 | 2.24% |
| Man Investments (CH) AG | 3,000,000 | $2,798,000 | 1.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,500,000 | $39,540,000 | 1.52% |
| MACKAY SHIELDS LLC | 17,069,000 | $15,982,000 | 0.73% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 73,035,000 | $68,425,000 | 0.63% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,307,000 | $39,554,000 | 0.61% |
| LINDEN ADVISORS LP | 14,122,000 | $13,194,000 | 0.49% |
| GLG LLC | 9,100,000 | $8,486,000 | 0.47% |
| Jabre Capital Partners S.A. | 3,400,000 | $3,179,000 | 0.38% |